← Back to Clinical Trials
Recruiting NCT06472505

Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage

Trial Parameters

Condition Pituitary Tumor
Sponsor National Taiwan University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2023-12-01
Completion 2025-12-31
Interventions
polyglycolic acid(Neoveil)

Brief Summary

The papers propose a new method to prevent postoperative cerebrospinal fluid leakage. Doctors use the absorbable polyglycolic acid (PGA) and fibrin glue to repair in surgery, prevent cerebrospinal fluid leakage and reduce the necessity of postoperative lumbar drainage after surgery. This study will analyze the changes in cerebrospinal fluid leakage in patients with pituitary tumors and skull base tumors after surgery, and further understand the effectiveness of Neoveil , as the basis for the development of new treatments.

Eligibility Criteria

A. Inclusion criteria 1\. Patients with primary or recurrent pituitary tumors require endoscopic nasal surgery. B. Exclusion criteria 1. Patients with pituitary gland tumors who do not receive surgical treatment. 2. Patients with other brain tumors. 3. Patients allergic to polyglycolic acid (PGA). 4. Patients who have had previous radiation therapy or chemotherapy.

Related Trials